Abstract

Activation of the interferon regulatory factors (IRFs) 3 and 7 transcription factors is essential for the induction of type I interferon (IFN) and development of the innate antiviral response. Retinoic acid-inducible gene I has been shown to contribute to virus-induced IFN production independent of the Toll-like receptor pathways in response to a variety of RNA viruses and double-stranded RNA. In the present study, we demonstrate that the NF-kappaB-inducible, anti-apoptotic protein A20 efficiently blocks RIG-I-mediated activation of NF-kappaB-, IRF-3-, and IRF-7-dependent promoters but only weakly interferes with TRIF-TLR-3-mediated IFN activation. Expression of A20 completely blocked CARD domain containing DeltaRIG-I-induced IRF-3 Ser-396 phosphorylation, homodimerization, and DNA binding. The level of A20 inhibition was upstream of the TBK1/IKKepsilon kinases that phosphorylate IRF3 and IRF7 and paradoxically, A20 selectively degraded the TRIF protein but not RIG-I. A20 possesses two ubiquitin-editing domains, an N-terminal deubiquitination domain and a C-terminal ubiquitin ligase domain consisting of seven zinc finger domains. Deletion of the N-terminal de-ubiquitination domain had no significant effect on the inhibitory effect of A20, whereas deletion or mutation of zinc finger motif 7 ablated the inhibitory function of A20 on IRF- or NF-kappaB-mediated gene expression. Furthermore, cells stably expressing the active form of RIG-I induced an antiviral state that interfered with replication of vesicular stomatitis virus, an effect that was reversed by stable co-expression of A20. These results suggest that the virus-inducible, NF-kappaB-dependent activation of A20 functions as a negative regulator of RIG-I-mediated induction of the antiviral state.

Highlights

  • Minating in the production of cytokines and chemokines that disrupt virus replication and initiate innate and adaptive immune responses [1,2,3]

  • Cells stably expressing the active form of retinoic acid-inducible gene I (RIG-I) induced an antiviral state that significantly blocked replication of VSV, an effect that was reversed by stable co-expression of A20

  • A20 Disrupts RIG-I Signaling—RIG-I signaling pathway leads to the activation of NF-␬B and interferon regulatory factors (IRFs) transcription factors, which are essential for the activation of IFNB promoter [36], and A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of interferon-stimulated response element (ISRE) promoter [42]

Read more

Summary

Introduction

Minating in the production of cytokines and chemokines that disrupt virus replication and initiate innate and adaptive immune responses [1,2,3]. Regulation of the TLR-independent, RIG-I signaling pathway leading to IRF-3 and NF-␬B has not been well defined, recent experiments suggest that the NF-␬B-inducible ubiquitin-editing protein A20 negatively regulates IRF-3 activation [41, 42]. Cells stably expressing the active form of RIG-I induced an antiviral state that significantly blocked replication of VSV, an effect that was reversed by stable co-expression of A20. These results demonstrate that virus-mediated activation of A20 functions as a negative regulator of RIG-I mediated induction of the antiviral state

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call